A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Laser-Induced Chronic Ocular Hypertension Model on SD Rats

11K views

⸱

DOI:

10.3791/549

⸱

December 4th, 2007

In This Article

Summary

Glaucoma is one of the major causes of blindness in the world. Elevated intraocular pressure is a major risk factor. Laser photocoagulation induced ocular hypertension is one of the well established animal models. This video demonstrates how to induce ocular hypertension by Argon laser photocoagulation in rat.

Abstract

Glaucoma is one of the major causes of blindness in the world. Elevated intraocular pressure is a major risk factor. Laser photocoagulation induced ocular hypertension is one of the well established animal models. This video demonstrates how to induce ocular hypertension by Argon laser photocoagulation in rat.

Protocol

Check and prepare the equipments

  1. Anaesthetize the rat by intra-peritoneal injection of ketamine (80mg/kg) and xylazine (8mg/kg) (volume ratio at 2:1).
  2. Apply one drop of 0.5% alcaine to the rat eyes as topical anesthetics before laser photocoagulation.
  3. Position the rat and expose the target veins with a curved forceps. Use the footstep to start laser photocoagulation. Apply bout 60 laser spots around the limbal vein (except the nasal area) and 15-20 laser spots on each episcleral aqueous humor drainage vein.

Laser photocoagulation

  1. Anaesthetize the rat by intra-peritoneal injection of ketamine (8....

Access restricted. Please log in or start a trial to view this content.

Discussion

After two laser treatments with 7 days apart, we can elevate the IOP of laser photocoagulated eye by 50% compare with control eye. The elevated IOP can sustain for at least for 3 month after first laser treatment. This rat model of elevated intraocular pressure provide valuable opportunities to study the mechanisms of pressure-induced retinal ganglion cell loss and optic nerve damage that mimic the pathological change in human glaucoma.

....

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
ULTIMA® 2000SE Argon Laser ToolCoherent Inc.
Protective gogglesOtherCoherent Inc.

References

  1. Chan, H. -C., Chang, R. C. C., Koon-Ching Ip, A., Chiu, K., Yuen, W. -H., Zee, S. -Y., So, K. -F. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma. Experimental Neurology. 203, 269-273 (2007).
  2. Ji, J. -Z., Elyaman, W., Yip, H. K., Lee, V. W. H., Yick, L. -W., Hugon, J., So, K. -F.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Laser PhotocoagulationIntraocular Pressure MeasurementArgon Laser TreatmentRat Glaucoma ModelEpiscleral Vein CoagulationLocal Anesthesia ApplicationAntibiotic Ointment Post-TreatmentSleep Lamp ExaminationKetamine Anesthesia Protocol